EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...
Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...
Her B2B career has taken her from corporate boardrooms to plant floors and underground mining stopes, covering everything ...
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move could jeopardize the availability of cheaper, generic forms of those drugs ...
Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...
Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2024 Novo Nordisk A/S Earnings Conference Call. At this time, all ...
Nektar Therapeutics is selling its Huntsville, Alabama, manufacturing plant and reagent supply business to private equity ...
A more tragic irony in the town is an obesity crisis among residents living in the shadow of the massive Wegovy-making plant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback